488.55
-0.30
(-0.06%)
At close: January 10 at 3:29:59 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
3,202,373.00
2,207,674.00
1,549,131.00
1,616,522.00
2,070,815.00
Investing Cash Flow
-2,872,691.00
-170,832.00
111,346.00
-1,445,669.00
-771,536.00
Financing Cash Flow
-108,576.00
-2,021,572.00
-1,799,501.00
-98,366.00
-1,293,490.00
End Cash Position
445,936.00
254,201.00
238,864.00
377,253.00
304,315.00
Capital Expenditure
-676,537.00
-933,932.00
-1,130,925.00
-1,325,442.00
-625,394.00
Repayment of Debt
-2,787.00
-759.00
-1,000.00
-1,357.00
-29,220.00
Repurchase of Capital Stock
--
-1,550,000.00
-1,377,500.00
--
-973,350.00
Free Cash Flow
2,525,836.00
1,273,742.00
418,206.00
291,080.00
1,445,421.00
3/31/2021 - 7/1/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NOVARTIND.BO Novartis India Limited
879.60
-3.76%
RPGLIFE.NS RPG Life Sciences Limited
2,112.25
-4.40%
WINDLAS.NS Windlas Biotech Limited
988.75
-2.69%
HIKAL.NS Hikal Limited
358.05
-3.66%
HESTERBIO.NS Hester Biosciences Limited
2,264.20
-3.48%
SOLARA.BO Solara Active Pharma Sciences Limited
655.15
-3.89%
AMRUTANJAN.NS Amrutanjan Health Care Limited
702.45
-1.11%
UNICHEMLAB.NS Unichem Laboratories Limited
692.65
-1.14%
INDOCO.NS Indoco Remedies Limited
327.80
-1.90%
JAGSNPHARM.BO Jagsonpal Pharmaceuticals Limited
214.00
-7.74%